Document Detail


Intrauterine growth restriction, brain-sparing effect, and neurotrophins.
MedLine Citation:
PMID:  17308153     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intrauterine growth restriction (IUGR) is failure of the fetus to achieve his or her intrinsic growth potential, due to anatomical/functional diseases or disorders in the feto-placental-maternal unit. Growth restriction successfully balances reduced oxygen delivery and consumption; however, chronic hypoxia is responsible for fetal blood flow redistribution to cardinal organs (brain, myocardium, and adrenal glands), the so-called brain-sparing effect. The neurotrophin family comprises four structurally related molecules: the nerve growth factor (NGF), the brain-derived neurotrophic factor (BDNF), the neurotrophin-3 (NT-3), and the neurotrophin-4 (NT-4). By exerting neuroprotection, neurotrophins are critical for pre- and postnatal brain development. Based on the assumption that the brain-sparing effect might be activated in full-term IUGR infants, we hypothesized that circulating neurotrophin levels should not differ between IUGR and appropriate for gestational age (AGA) infants. Indeed, we found that in both groups, circulating NT-3, NT-4, and BDNF levels do not differ, and this finding could possibly be attributed to the activation of the brain-sparing effect. In contrast, NGF levels were higher in the AGA compared to the IUGR group. However, only NGF levels positively correlated with the customized centile and the birth weight of the infants, and both of them were lower in the IUGR group.
Authors:
Ariadne Malamitsi-Puchner; K E Nikolaou; K-P Puchner
Related Documents :
6602073 - Regional cerebral glucose metabolism of newborn infants measured by positron emission t...
8252903 - Brain death in the pediatric patient: historical, sociological, medical, religious, cul...
8195953 - Helminths of the black bear, ursus americanus, in new brunswick.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annals of the New York Academy of Sciences     Volume:  1092     ISSN:  0077-8923     ISO Abbreviation:  Ann. N. Y. Acad. Sci.     Publication Date:  2006 Dec 
Date Detail:
Created Date:  2007-02-19     Completed Date:  2007-04-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7506858     Medline TA:  Ann N Y Acad Sci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  293-6     Citation Subset:  IM    
Affiliation:
Neonatal Division, Second Department of Obstetrics and Gynecology, University of Athens, 19, Soultani Str., GR-10682 Athens, Greece. malamitsi@aias.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain-Derived Neurotrophic Factor / blood
Female
Fetal Growth Retardation / blood*
Humans
Nerve Growth Factor / blood
Nerve Growth Factors / blood
Neurotrophin 3 / blood
Pregnancy
Chemical
Reg. No./Substance:
0/Brain-Derived Neurotrophic Factor; 0/Nerve Growth Factors; 0/Neurotrophin 3; 143551-63-7/neurotrophin 4; 9061-61-4/Nerve Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Recent developments in the detection of fetal single gene differences in maternal plasma and the rol...
Next Document:  Doppler assessment of the intrauterine growth-restricted fetus.